Newsroom | 220279 results

BOSTON--(BUSINESS WIRE)--WHOOP, la empresa especializada en rendimiento humano, presentó una nueva serie de funciones de salud impulsadas por inteligencia artificial para sus membresías, en un nuevo paso dentro de su evolución hacia una plataforma inteligente de salud. Estas incorporaciones refuerzan el compromiso de la empresa con el desarrollo de información más personalizada, precisa y accionable, y amplían su propuesta más allá de la optimización del rendimiento para sumar herramientas de s...

ボストン--(BUSINESS WIRE)--（ビジネスワイヤ） -- フープ（WHOOP）は、ヒューマンパフォーマンス企業です。同社は、フープの各メンバーシップにおけるヘルスおよびAI主導の複数の機能強化と機能アップデートを発表し、インテリジェント・ヘルス・プラットフォームへの進化において大きな一歩を踏み出しました。これらのアップデートは、高度にパーソナライズされ、正確で実践に役立つインサイトを提供するという同社の取り組みをさらに強化するものです。また、同社がパフォーマンス最適化を超え、臨床グレードの健康支援へと拡大していることを示しています。 フープの最高製品責任者であるエド・ベイカーは、次のように述べています。「フープはメンバーシップサービスであり、私たちはその意味を真摯に受け止めています。フープでは、メンバーにより大きな価値を提供するにはどうすればよいかを常に問い続けています。臨床医によるサポートをアプリ内に直接導入することから、AIコーチングをこれまで以上に個人に合わせ、実践につなげやすいものへ進化させることまで、今後提供予定のこれらの機能は、フープがこれまで構築してきた中...

HASLET, Texas--(BUSINESS WIRE)--Davidson Bogel Real Estate (DB2RE) is pleased to announce the sale of approximately 7 acres of land located at the southwest corner of Haslet Parkway and Harmon Road in Haslet, Texas. Collins Meier, Ryan Turner, David Davidson, Jr., and Edward Bogel represented the seller in the transaction. The buyer, Encompass Health, partnered closely with the land owner and master developer, Terra Manna, to bring the project to fruition. JLL represented the buyer in the trans...

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June 30, 2025. First Half of 2025 Financial Summary Sales for the six months ended June 30, 2025 were $130.3 million, compared to $128.7 million in the prior year period. The Company posted $21.7 million of net loss attributable to common shareholders, or a loss of $0.30 per...

MIAMI--(BUSINESS WIRE)--Coolibar, the world’s leading UPF 50+ sun protection apparel brand, is continuing its partnership with skin cancer survivor and advocate Dayanara Torres and the Melanoma Research Foundation (MRF) for Skin Cancer Awareness Month this May. The 2026 campaign brings a more intimate and elevated creative direction to Coolibar’s sun safety message, using emotional storytelling to encourage prevention, protection, and early detection. Together, the partners aim to reach communi...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, announces that its Annual Meeting of Shareholders will be held virtually at 9:00 am PDT on Monday, June 29, 2026. After the meeting materials are finalized and filed with the Securities and Exchanges Commission, such materials will be mailed to shareholders. The Company also advises its Financial Statements included in its Annual Report o...

BOSTON--(BUSINESS WIRE)--Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced the presentation of initial clinical data from the first participant dosed in its Phase 1/2 trial of EN-374 for the treatment of X-linked chronic granulomatous disease (X-CGD) at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting, taking place May 11-15 in Boston. The data represent the first reported clini...

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG) (“TruBridge”), a leading provider of healthcare technology solutions for rural and community hospitals, today announced financial results for the first quarter ended March 31, 2026. Recent Developments As previously announced on April 23, 2026, TruBridge announced a definitive agreement whereby TruBridge, Inc. will be acquired by Inventurus Knowledge Solutions, Inc. (“IKS”), the U.S. subsidiary of Inventurus Knowledge Solutions Limit...

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that the NYSE American LLC (the “NYSE American") has accepted the Company’s previously submitted plan to regain compliance with continued listing standards. As previously disclosed on March 12, 2026, the Company was notified that it was not in compliance with Section 1003 (a) of the NYSE American Co...

NEW YORK--(BUSINESS WIRE)--KBRA assigns a long-term rating of AA+ to the Harris County Hospital District's, TX (the "District") Series 2026, Limited Tax and Refunding Bonds. Concurrently, KBRA affirms the long-term AA+ rating for outstanding limited tax bonds. The Rating Outlook is Stable. Key Credit Considerations The rating actions reflect the following key credit considerations: Credit Positives A growing tax base continues to generate strong property tax revenues for the District, thus supp...